1
TÍTULO: FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
AUTORES: Oliveira, M; Saura, C; Nuciforo, P; Calvo, I; Andersen, J; Passos Coelho, JL; Gil Gil, MG; Bermejo, B; Patt, DA; Ciruelos, E; de la Pena, L; Xu, N; Wongchenko, M; Shi, Z; Singel, SM; Isakoff, SJ;
PUBLICAÇÃO: 2019, FONTE: ANNALS OF ONCOLOGY, VOLUME: 30, NÚMERO: 8
INDEXADO EM: Scopus WOS